Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 30 May, 2024|Author: Getaka | Social: X Twitter Profile

Fundamental Analysis of Caplin Point Laboratories Ltd

About the Company - Caplin Point Laboratories Ltd

Caplin Point Laboratories Ltd. is a Public Limited Listed company incorporated on 16/04/1990 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L24231TN1990PLC019053 and registration number is 019053. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 528.06 Cr. and Equity Capital is Rs. 15.16 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
Pharmaceuticals3rd Floor, Ashvich Towers, Chennai (Madras) Tamil Nadu 600096investor@caplinpoint.net
http://www.caplinpoint.net
Management
NamePosition Held
Mr. C C PaarthipanChairman
Dr. Sridhar GanesanManaging Director
Dr. R NagendranIndependent Director
Mr. S DeenadayalanIndependent Director
Mr. D SathyanarayananIndependent Director
Dr. C K GariyaliIndependent Director

Basic Stock Data of Caplin Point Laboratories Ltd

Last Updated: May 13, 2024, 4:20 pm

Market Cap 9,920 Cr.
Current Price 1,306
High / Low1,619/690
Stock P/E22.7
Book Value 273
Dividend Yield0.34 %
ROCE26.3 %
ROE25.6 %
Face Value 2.00
PEG Ratio1.49

Competitors of Caplin Point Laboratories Ltd

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
Beryl Drugs Ltd 17.9 Cr. 35.445.0/13.115.3 17.80.00 %11.6 %10.0 % 10.0
Biocon Ltd 32,710 Cr. 272307/21227.3 1580.56 %5.92 %4.78 % 5.00
Bafna Pharmaceuticals Ltd 209 Cr. 88.5126/75.918.6 34.80.00 %15.9 %16.4 % 10.0
TTK Healthcare Ltd 2,081 Cr. 1,4741,744/1,10133.1 7080.68 %8.67 %6.43 % 10.0
Abbott India Ltd 56,000 Cr. 26,35329,639/21,45046.6 1,7410.69 %46.0 %34.9 % 10.0
Industry Average18,203.58 Cr5,644.5828.18531.920.39%17.62%14.50%9.00

Caplin Point Laboratories Ltd Quarterly Results

MonthDec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Sales274279300304326339346359372389395410436
Expenses190193208202225239244253263265269273293
Operating Profit848693101101100102106109124127137142
OPM %31%31%31%33%31%29%30%29%29%32%32%34%33%
Other Income6998101214161411122117
Interest0000000000000
Depreciation9101212121111111111111214
Profit before tax8085909899100105110112124127146145
Tax %18%20%20%21%20%19%18%17%13%18%18%20%18%
Net Profit666872777981869297101104116120
EPS in Rs8.528.779.379.919.8910.4311.2112.0912.8413.4513.6215.1315.43

Last Updated: May 11, 2024, 11:50 am

Caplin Point Laboratories Ltd Quarterly Chart

Caplin Point Laboratories Ltd Profit & Loss

Last Updated: May 29, 2024, 10:59 am

MonthJun 2012Jun 2013Jun 2014Jun 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Sales1071271732522394025406498631,0611,2691,4671,630
Expenses961051371921752763454176037328741,0251,100
Operating Profit1122366064125195232260329395442530
OPM %10%18%21%24%27%31%36%36%30%31%31%30%33%
Other Income324341013194123385561
Interest1111011102111
Depreciation124871319233237474548
Profit before tax1122365360121188227269314386451542
Tax %28%37%27%23%24%21%23%22%20%20%20%16%
Net Profit81426414696145177215251308377441
EPS in Rs1.061.853.425.436.0512.6519.1523.3528.4232.0339.5649.5757.63
Dividend Payout %38%27%23%18%20%12%10%9%9%9%10%9%

Caplin Point Laboratories Ltd Profit & Loss Yearly Chart

Caplin Point Laboratories Ltd Growth

Compounded Sales Growth
10 Years:30%
5 Years:21%
3 Years:17%
TTM:16%
Compounded Profit Growth
10 Years:42%
5 Years:21%
3 Years:24%
TTM:22%
Stock Price CAGR
10 Years:44%
5 Years:26%
3 Years:30%
1 Year:77%
Return on Equity
10 Years:28%
5 Years:25%
3 Years:25%
Last Year:23%

Last Updated: May 13, 2024, 4:20 pm

Caplin Point Laboratories Ltd Balance Sheet

MonthJun 2012Jun 2013Jun 2014Jun 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital15151515151515151515151515
Reserves182847781132103495828589541,2521,6492,058
Preference Capital00000003675217217217
Borrowings753221113918253
Other Liabilities6787115134137133136145214376467522336
Total Liabilities1071351802292673585007431,1261,3641,7362,1912,413
Fixed Assets2833102113144152169227272305287280280
CWIP13512531031510201418221275
Investments11000174770611189230246
Other Assets665052851221862694367721,0331,3431,4611,611
Total Assets1071351802292673585007431,1261,3641,7362,1912,413

Caplin Point Laboratories Ltd Reserves and Borrowings Chart

Caplin Point Laboratories Ltd Cash Flow

MonthJun 2012Jun 2013Jun 2014Jun 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Cash from Operating Activity 283260504268668345269337271
Cash from Investing Activity -16-45-44-23-6-36-69-100-54-30-377-216
Cash from Financing Activity -1-1-6-9-14-7-129080-24-41-28
Net Cash Flow10-1510192325-147370215-8127

Caplin Point Laboratories Ltd Financial Efficiency Indicators

MonthJun 2012Jun 2013Jun 2014Jun 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Debtor Days252081230859097969198
Inventory Days3045353757444447210139149159
Days Payable10011111211216815514476576810290
Cash Conversion Cycle-45-63-77-67-99-81-1661251166138166
Working Capital Days-143-176-181-128-114-2947104167152166159
ROCE %31%52%64%68%62%68%63%45%33%28%28%26%

Caplin Point Laboratories Ltd Financial Efficiency Indicators Chart

Caplin Point Laboratories Ltd Share Holding Pattern

MonthDec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
Promoters69.03%69.03%69.03%69.03%68.91%68.89%68.88%68.88%68.80%70.66%70.63%70.62%
FIIs1.64%0.68%1.15%1.76%2.11%2.07%2.03%2.15%2.24%2.36%2.68%3.09%
DIIs1.10%1.28%1.48%1.19%1.22%1.25%1.12%1.12%1.12%0.64%0.27%0.21%
Public28.23%29.01%28.34%28.02%27.76%27.78%27.97%27.85%27.84%26.33%26.44%26.08%
No. of Shareholders66,49868,07669,52483,46285,57783,82984,86884,53882,68782,14678,95678,068

Caplin Point Laboratories Ltd Shareholding Pattern Chart

No. of Caplin Point Laboratories Ltd Shareholders

Caplin Point Laboratories Ltd Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)
Motilal Oswal Nifty Microcap 250 Index Fund218540.482.74
ICICI Prudential S&P BSE 500 ETF2240.020.03
Motilal Oswal S&P BSE Healthcare ETF2340.320.03
Groww Nifty Total Market Index Fund560.020.01
HDFC S&P BSE 500 ETF110.020
HDFC S&P BSE 500 Index Fund360.020

Caplin Point Laboratories Ltd ROCE Trend

Caplin Point Laboratories Ltd EPS Trend

Caplin Point Laboratories Ltd Key Financial Ratios

MonthMar 23Mar 22Mar 21Mar 20Mar 19
FaceValue2.002.002.002.002.00
Basic EPS (Rs.)49.6239.6132.0328.4223.35
Diluted EPS (Rs.)49.1839.2631.7128.2023.23
Cash EPS (Rs.)55.6046.8838.1332.6126.44
Book Value[Excl.RevalReserv]/Share (Rs.)241.46189.35159.08116.6078.94
Book Value[Incl.RevalReserv]/Share (Rs.)241.46189.35159.08116.6078.94
Revenue From Operations / Share (Rs.)193.25167.47140.30114.1285.77
PBDIT / Share (Rs.)65.4957.1846.5639.8533.10
PBIT / Share (Rs.)59.5650.9941.6735.6630.01
PBT / Share (Rs.)59.4750.9041.4635.6230.00
Net Profit / Share (Rs.)49.6740.6933.2428.4323.34
NP After MI And SOA / Share (Rs.)49.5739.5632.0328.4223.35
PBDIT Margin (%)33.8834.1433.1834.9138.59
PBIT Margin (%)30.8230.4429.7031.2534.98
PBT Margin (%)30.7730.3929.5531.2134.97
Net Profit Margin (%)25.7024.2923.6924.9127.21
NP After MI And SOA Margin (%)25.6523.6222.8224.9027.21
Return on Networth / Equity (%)20.8321.2720.4324.6129.57
Return on Capital Employeed (%)23.5025.2825.8227.4834.57
Return On Assets (%)17.1617.2617.7619.0923.77
Total Debt / Equity (X)0.000.000.010.040.00
Asset Turnover Ratio (%)0.740.430.480.731.03
Current Ratio (X)5.806.257.255.705.73
Quick Ratio (X)4.725.156.004.055.30
Inventory Turnover Ratio (X)0.801.410.853.203.62
Dividend Payout Ratio (NP) (%)8.050.001.240.000.00
Dividend Payout Ratio (CP) (%)7.190.001.080.000.00
Earning Retention Ratio (%)91.950.0098.760.000.00
Cash Earning Retention Ratio (%)92.810.0098.920.000.00
Interest Coverage Ratio (X)637.23619.17221.55942.764172.69
Interest Coverage Ratio (Post Tax) (X)484.22441.64159.17673.772943.59
Enterprise Value (Cr.)4065.674717.102632.141957.492890.37
EV / Net Operating Revenue (X)2.773.722.482.274.46
EV / EBITDA (X)8.1810.887.476.4911.54
MarketCap / Net Operating Revenue (X)3.094.062.882.474.69
Retention Ratios (%)91.940.0098.750.000.00
Price / BV (X)2.513.662.582.455.10
Price / Net Operating Revenue (X)3.094.062.882.474.69
EarningsYield0.080.050.070.100.05

Caplin Point Laboratories Ltd Profitability Ratios (%)

Caplin Point Laboratories Ltd Liquidity Ratios

Caplin Point Laboratories Ltd Liquidity Ratios (%)

Caplin Point Laboratories Ltd Interest Coverage Ratios (%)

Caplin Point Laboratories Ltd Valuation Ratios

Fair Value

Fair Value: ₹1,591.85

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

Undervalued: 21.89% compared to the current price ₹1306

Intrinsic Value: ₹1,833.61

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators along with EPS growth.

Undervalued: 40.40% compared to the current price ₹1306

Last 5 Year EPS CAGR: 15.19%

*Investments are subject to market risks

Strength and Weakness of Caplin Point Laboratories Ltd Stock

StrengthWeakness
  1. The stock has a high average ROCE of 47.33%, which is a positive sign.
  2. The stock has a low average Working Capital Days of 2.00, which is a positive sign.
  3. The company has higher reserves (630.46 cr) compared to borrowings (58.62 cr), indicating strong financial stability.
  4. The company has shown consistent growth in sales (258.15 cr) and profit (206.15 cr) over the years.
  1. The stock has a high average Cash Conversion Cycle of 27.83, which may not be favorable.

FAQ

What is the latest fair value of Caplin Point Laboratories Ltd?

The latest fair value of Caplin Point Laboratories Ltd is ₹1591.85.

What is the Market Cap of Caplin Point Laboratories Ltd?

The Market Cap of Caplin Point Laboratories Ltd is 9,920 Cr..

What is the current Stock Price of Caplin Point Laboratories Ltd as on 30 May 2024?

The current stock price of Caplin Point Laboratories Ltd as on 30 May 2024 is ₹1,306.

What is the High / Low of Caplin Point Laboratories Ltd stocks in FY 2024?

In FY 2024, the High / Low of Caplin Point Laboratories Ltd stocks is 1,619/690.

What is the Stock P/E of Caplin Point Laboratories Ltd?

The Stock P/E of Caplin Point Laboratories Ltd is 22.7.

What is the Book Value of Caplin Point Laboratories Ltd?

The Book Value of Caplin Point Laboratories Ltd is 273.

What is the Dividend Yield of Caplin Point Laboratories Ltd?

The Dividend Yield of Caplin Point Laboratories Ltd is 0.34 %.

What is the ROCE of Caplin Point Laboratories Ltd?

The ROCE of Caplin Point Laboratories Ltd is 26.3 %.

What is the ROE of Caplin Point Laboratories Ltd?

The ROE of Caplin Point Laboratories Ltd is 25.6 %.

What is the Face Value of Caplin Point Laboratories Ltd?

The Face Value of Caplin Point Laboratories Ltd is 2.00.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Caplin Point Laboratories Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE